3-[6-[3-[4-phenyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]-3,4-dihydro-1H-isoquinolin-2-yl]propanoic acid
C27H22F3N3O3 — CID 11179414
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[6-[3-[4-phenyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]-3,4-dihydro-1H-isoquinolin-2-yl]propanoic acid
3-[6-[3-[4-phenyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]-3,4-dihydro-1H-isoquinolin-2-yl]propanoic acid (PubChem CID 11179414) has the molecular formula C27H22F3N3O3 and a molecular weight of 493.49 g/mol. Its IUPAC name is 3-[6-[3-[4-phenyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]-3,4-dihydro-1H-isoquinolin-2-yl]propanoic acid.
Molecular Properties
| Compound Name | 3-[6-[3-[4-phenyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]-3,4-dihydro-1H-isoquinolin-2-yl]propanoic acid |
|---|---|
| PubChem CID | 11179414 |
| Molecular Formula | C27H22F3N3O3 |
| Molecular Weight | 493.49 g/mol |
| Exact Mass | 493.16 |
| IUPAC Name | 3-[6-[3-[4-phenyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]-3,4-dihydro-1H-isoquinolin-2-yl]propanoic acid |
| SMILES | O=C(O)CCN1CCc2cc(-c3nc(-c4ccc(-c5ccccc5)c(C(F)(F)F)c4)no3)ccc2C1 |
| InChI | InChI=1S/C27H22F3N3O3/c28-27(29,30)23-15-19(8-9-22(23)17-4-2-1-3-5-17)25-31-26(36-32-25)20-6-7-21-16-33(13-11-24(34)35)12-10-18(21)14-20/h1-9,14-15H,10-13,16H2,(H,34,35) |
| InChIKey | HHQIHZFHNGEQNN-UHFFFAOYSA-N |
| XLogP | 5.92 |
| TPSA | 79.46 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 493.49 |
| LogP ≤ 5 | 5.92 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 11179414 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.